View on Pubmed.gov 26251237 | View on doi.org 10.1007/s00281-...
β-amyloid, microglia, and the inflammasome in Alzheimer's disease.
- Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, 02129, USA.
- Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, 02129, USA. jelkhoury@mgh.harvard.edu.
Abstract
There is extensive evidence that accumulation of mononuclear phagocytes including microglial cells, monocytes, and macrophages at sites of β-amyloid (Aβ) deposition in the brain is an important pathological feature of Alzheimer's disease (AD) and related animal models, and the concentration of these cells clustered around Aβ deposits is several folds higher than in neighboring areas of the brain [1-5]. Microglial cells phagocytose and clear debris, pathogens, and toxins, but they can also be activated to produce inflammatory cytokines, chemokines, and neurotoxins [6]. Over the past decade, the roles of microglial cells in AD have begun to be clarified, and we proposed that these cells play a dichotomous role in the pathogenesis of AD [4, 6-11]. Microglial cells are able to clear soluble and fibrillar Aβ, but continued interactions of these cells with Aβ can lead to an inflammatory response resulting in neurotoxicity. Inflammasomes are inducible high molecular weight protein complexes that are involved in many inflammatory pathological processes. Recently, Aβ was found to activate the NLRP3 inflammasome in microglial cells in vitro and in vivo thereby defining a novel pathway that could lead to progression of AD [12-14]. In this manuscript, we review possible steps leading to Aβ-induced inflammasome activation and discuss how this could contribute to the pathogenesis of AD.
References
Immunity. 2013 Dec 12;39(6):1003-18
Physiol Rev. 2011 Apr;91(2):461-553
Nat Immunol. 2010 May;11(5):395-402
Nat Immunol. 2014 Aug;15(8):738-48
Cited by 168 citations (total)
Journal Article
NLRP3 Inflammasome Activation in a Transgenic Amyotrophic Lateral Sclerosis Model.
Electronic publication date September 25, 2018
Agnese Gugliandolo [...] Emanuela Mazzon et al.
Amyotrophic lateral sclerosis (ALS) is a disabling progressive disease characterized by the degeneration of motor neurons, leading to muscle atrophy...
Journal Article Research Support, N.I.H., Extramural Review
The intricate biophysical puzzle of caspase-1 activation.
Electronic publication date March 26, 2021
Nyasha J Makoni [...] Michael R Nichols et al.
This review takes a closer look at the structural components of the molecules involved in the processes leading to caspase-1...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
Substances
- •
- •
- •
- •
- •